Efficacy of a Food Supplement Containing
Humans
Quality of Life
Gastroesophageal Reflux
/ drug therapy
Male
Double-Blind Method
Female
Adult
Dietary Supplements
Probiotics
/ administration & dosage
Middle Aged
Lactobacillus acidophilus
Vitamins
/ administration & dosage
Treatment Outcome
Peptides
/ administration & dosage
Heartburn
/ drug therapy
Surveys and Questionnaires
Severity of Illness Index
GERD
QoL
bioactive peptides
clinical trial
probiotics
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
04 Jun 2024
04 Jun 2024
Historique:
received:
07
05
2024
revised:
27
05
2024
accepted:
31
05
2024
medline:
19
6
2024
pubmed:
19
6
2024
entrez:
19
6
2024
Statut:
epublish
Résumé
Dietary interventions represent an interesting alternative to pharmacological treatments for improving the quality of life (QoL) of subjects suffering from gastroesophageal reflux disease (GERD). This randomized, double-blind, placebo-controlled study aimed to evaluate the efficacy of a food supplement (FS) containing a probiotic strain, bioactive peptides, and vitamins in relieving heartburn/dyspeptic symptoms in subjects with mild-to-moderate GERD. Fifty-six adult participants were randomly assigned to receive the placebo or the active FS for 28 days. Subjects were asked to record daily the frequency and intensity of heartburn episodes and the intake of over- the-counter (OTC) medications. GERD-QoL and self-assessment questionnaires were also completed every two weeks and at the end of the treatment, respectively. FS was effective in achieving a progressive and significant reduction of heartburn frequency and severity, with an intergroup significant difference at the end of the treatment period. FS group also reported a reduction in the OTC medication intake, whereas placebo administration did not modify the OTC intake. Results from the QoL and self-assessment questionnaires showed that FS administration achieved a progressive and statistically significant intragroup and intergroup improvement in the QoL score and a higher positive response with respect to the placebo treatment.
Identifiants
pubmed: 38892690
pii: nu16111759
doi: 10.3390/nu16111759
pii:
doi:
Substances chimiques
Vitamins
0
Peptides
0
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM